Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-01-09
DOI
10.3389/fphar.2018.01526
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study
- (2018) Jurgen Sota et al. CLINICAL RHEUMATOLOGY
- THE BROAD-RANGING PANORAMA OF SYSTEMIC AUTOINFLAMMATORY DISORDERS WITH SPECIFIC FOCUS ON ACUTE PAINFUL SYMPTOMS AND HEMATOLOGIC MANIFESTATIONS IN CHILDREN
- (2018) Donato Rigante Mediterranean Journal of Hematology and Infectious Diseases
- Investigational drugs for treatment of juvenile idiopathic arthritis
- (2017) Angela Mauro et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- A systematic approach to autoinflammatory syndromes: a spelling booklet for the beginner
- (2017) Donato Rigante Expert Review of Clinical Immunology
- Course, Outcome and Complications in Children with Systemic Onset Juvenile Idiopathic Arthritis
- (2017) Mansi Dewoolkar et al. INDIAN JOURNAL OF PEDIATRICS
- Bridging the Gap between the Clinician and the Patient with Cryopyrin-Associated Periodic Syndromes
- (2017) L. Cantarini et al. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
- Mortality rates are increased in patients with systemic juvenile idiopathic arthritis
- (2016) Rebecca Davies et al. ARCHIVES OF DISEASE IN CHILDHOOD
- Systemic-onset juvenile idiopathic arthritis
- (2016) Rolando Cimaz AUTOIMMUNITY REVIEWS
- Systemic Juvenile Idiopathic Arthritis: Diagnosis and Management
- (2016) Sathish Kumar INDIAN JOURNAL OF PEDIATRICS
- Anakinra in Systemic Juvenile Idiopathic Arthritis: A Single-center Experience
- (2015) M. Pardeo et al. JOURNAL OF RHEUMATOLOGY
- Treatment of juvenile idiopathic arthritis: a revolution in care
- (2014) Matthew L Stoll et al. Pediatric Rheumatology
- 2013 Update of the 2011 American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for the Medical Therapy of Children With Systemic Juvenile Idiopathic Arthritis and Tuberculosis Screening Among C
- (2014) Sarah Ringold et al. ARTHRITIS CARE & RESEARCH
- Clinical Features, Treatment, and Outcome of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A Multinational, Multicenter Study of 362 Patients
- (2014) Francesca Minoia et al. Arthritis & Rheumatology
- Review: Is There a Window of Opportunity for Treatment of Systemic Juvenile Idiopathic Arthritis?
- (2014) Peter A. Nigrovic Arthritis & Rheumatology
- Effectiveness of First-Line Treatment With Recombinant Interleukin-1 Receptor Antagonist in Steroid-Naive Patients With New-Onset Systemic Juvenile Idiopathic Arthritis: Results of a Prospective Cohort Study
- (2013) Sebastiaan J. Vastert et al. Arthritis & Rheumatology
- Effectiveness and safety of a second and third biological agent after failing etanercept in juvenile idiopathic arthritis: results from the Dutch National ABC Register
- (2012) Marieke H Otten et al. ANNALS OF THE RHEUMATIC DISEASES
- Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis
- (2012) Nicolino Ruperto et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions
- (2011) Elizabeth D. Mellins et al. Nature Reviews Rheumatology
- Anakinra: A safe and effective first-line treatment in systemic onset juvenile idiopathic arthritis (SoJIA)
- (2011) C. M. Hedrich et al. RHEUMATOLOGY INTERNATIONAL
- A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)
- (2010) P. Quartier et al. ANNALS OF THE RHEUMATIC DISEASES
- Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: Report of forty-six patients from an international multicenter series
- (2010) Peter A. Nigrovic et al. ARTHRITIS AND RHEUMATISM
- Clinical Remission in Patients with Systemic Juvenile Idiopathic Arthritis Treated with Anti-Tumor Necrosis Factor Agents
- (2009) R. A.G. RUSSO et al. JOURNAL OF RHEUMATOLOGY
- Drug survival of the first and second course of anti-tumour necrosis factor agents in juvenile idiopathic arthritis
- (2008) P Tynjala et al. ANNALS OF THE RHEUMATIC DISEASES
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started